Idiopathic Thrombocytopenic Purpura

What Compensation is Available for ITP from a Vaccine?

Idiopathic thrombocytopenic purpura (ITP) is a potentially serious blood disorder that has been linked to the measles, mumps and rubella (MMR) vaccines for children and adults. When an MMR vaccine recipient’s ITP results in inpatient treatment or lasts six months or longer, the recipient (or the recipient’s family) may be eligible to file a claim … Continue reading →